P/B
—
Bruker
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
$9.4B
Market Cap • 9/18/2026
1991
(35 years)
Founded
2000
(26 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
2,7
P/EBITDA
46,9
P/OCF
49,1
P/FCF
99,6
P/E
—
BVPS
—
EPS
—
Market Cap
Market Cap
9,4B
EV
11B
EV/Revenue
3,2
EV/EBITDA
55,3
EV/EBIT
-360,4
Payout
Dividend Per Share
0,1
Dividend Yield
0,2%
Buyback Yield
0%
Total Yield
0,2%
Dividend Yield 5Y
0,3%
Payout
-21,1%
Profitability
Gross Margin
46,4%
EBITDA Margin
5,7%
EBIT Margin
—
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
11,2%
Capex/Revenue
2,8%
Capex/D&A
41,9%
Capex/OCF
50,7%
SBC/OCF
—
% PPE
11,8%
% Goodwill
38%
ROE
—
ROIC
—
Growth
CAGR Revenue 5Y
9,1%
CAGR OCF 5Y
-14%
Leverage
N.D./EBITDA
8,2
Debt/Equity
0%
Current Ratio
1,8
Quick Ratio
0,6
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!